A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen

• Status: Completed
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine which of two delivery methods of Parathyroid Hormone (PTH) is preferred by patients after 14 days of use for each.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zosano Pharma Corporation; Zosano Pharma Inc.
• Treatments: Hormones; Parathyroid Hormone; Teriparatide

Criteria

Inclusion Criteria:

• Postmenopausal with prior diagnosis of osteoporosis

Exclusion Criteria:

• Significant health issue

• previous use of teriparatide

• History of Paget's disease